Ubs Group Ag Charles River Laboratories International, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 163,916 shares of CRL stock, worth $30.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

163,916

Previous 146,442 11.93%

Holding current value

$30.8 Million

Previous $30.3 Million 6.74%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$187.96 - $245.29 $3.28 Million - $4.29 Million	17,474 Added 11.93%	163,916 $32.3 Million
Q2 2024 Aug 13, 2024	BUY	$206.39 - $268.73 $5.22 Million - $6.8 Million	25,295 Added 20.88%	146,442 $30.3 Million
Q1 2024 May 13, 2024	BUY	$203.52 - $273.43 $5.35 Million - $7.18 Million	26,272 Added 27.69%	121,147 $32.8 Million
Q4 2023 Feb 09, 2024	SELL	$164.52 - $238.84 $1.17 Million - $1.7 Million	-7,137 Reduced 7.0%	94,875 $22.4 Million
Q3 2023 Nov 09, 2023	SELL	$194.44 - $217.61 $1.72 Million - $1.93 Million	-8,850 Reduced 7.98%	102,012 $20 Million
Q2 2023 Aug 11, 2023	BUY	$183.71 - $210.25 $431,902 - $494,297	2,351 Added 2.17%	110,862 $23.3 Million
Q1 2023 May 12, 2023	BUY	$191.89 - $259.92 $4.62 Million - $6.25 Million	24,061 Added 28.49%	108,511 $21.9 Million
Q4 2022 Feb 08, 2023	BUY	$197.11 - $250.07 $6.04 Million - $7.67 Million	30,663 Added 57.01%	84,450 $18.4 Million
Q3 2022 Nov 10, 2022	BUY	$182.44 - $250.54 $4.37 Million - $6 Million	23,931 Added 80.15%	53,787 $10.6 Million
Q2 2022 Aug 10, 2022	SELL	$204.13 - $302.4 $4.63 Million - $6.86 Million	-22,669 Reduced 43.16%	29,856 $6.39 Million
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $7.08 Million - $10 Million	-27,695 Reduced 34.52%	52,525 $14.9 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $3.28 Million - $4.19 Million	-9,338 Reduced 10.43%	80,220 $30.2 Million
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $5.47 Million - $6.73 Million	14,676 Added 19.6%	89,558 $37 Million
Q2 2021 Aug 13, 2021	BUY	$294.17 - $371.65 $5.35 Million - $6.76 Million	18,186 Added 32.08%	74,882 $27.7 Million
Q1 2021 May 12, 2021	SELL	$249.67 - $299.48 $2.11 Million - $2.53 Million	-8,434 Reduced 12.95%	56,696 $16.4 Million
Q4 2020 Feb 11, 2021	BUY	$222.0 - $252.62 $3.52 Million - $4.01 Million	15,874 Added 32.23%	65,130 $16.3 Million
Q3 2020 Nov 12, 2020	BUY	$175.56 - $226.45 $4.92 Million - $6.34 Million	28,000 Added 131.73%	49,256 $11.2 Million
Q2 2020 Jul 31, 2020	SELL	$118.84 - $189.72 $75,701 - $120,851	-637 Reduced 2.91%	21,256 $3.71 Million
Q1 2020 May 01, 2020	SELL	$98.9 - $178.34 $5.55 Million - $10 Million	-56,121 Reduced 71.94%	21,893 $2.76 Million
Q4 2019 Feb 14, 2020	BUY	$126.05 - $152.76 $5.44 Million - $6.6 Million	43,182 Added 123.97%	78,014 $11.9 Million
Q3 2019 Nov 14, 2019	BUY	$125.07 - $143.67 $467,386 - $536,894	3,737 Added 12.02%	34,832 $4.61 Million
Q2 2019 Aug 14, 2019	SELL	$123.4 - $148.55 $435,725 - $524,530	-3,531 Reduced 10.2%	31,095 $4.41 Million
Q1 2019 May 14, 2019	BUY	$104.82 - $146.73 $115,301 - $161,403	1,100 Added 3.28%	34,626 $5.03 Million
Q4 2018 Feb 14, 2019	SELL	$105.09 - $137.23 $596,175 - $778,505	-5,673 Reduced 14.47%	33,526 $3.8 Million
Q3 2018 Nov 14, 2018	BUY	$112.11 - $134.54 $964,706 - $1.16 Million	8,605 Added 28.13%	39,199 $5.27 Million
Q2 2018 Aug 14, 2018	SELL	$102.37 - $117.25 $111,583 - $127,802	-1,090 Reduced 3.44%	30,594 $3.43 Million
Q1 2018 May 15, 2018	BUY	$98.19 - $115.2 $39,276 - $46,080	400 Added 1.28%	31,684 $3.38 Million
Q4 2017 Feb 14, 2018	SELL	$100.43 - $118.09 $705,119 - $829,109	-7,021 Reduced 18.33%	31,284 $3.42 Million
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $890,501 - $1.01 Million	9,207 Added 31.64%	38,305 $4.14 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-3,572 Reduced 10.93%	29,098 $2.94 Million
Q1 2017 Nov 14, 2017	BUY	N/A	32,670	32,670 $2.94 Million

Others Institutions Holding CRL

# of Institutions

694

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account